Publications & Posters
Scholarly publications
Spinal Muscular Atrophy
Apitegromab
October 2023
World Muscle Society 2023 Meeting
Effect of apitegromab on PEDI-CAT and PROMIS Fatigue questionnaire at 36 months in patients with spinal muscular atrophy
Spinal Muscular Atrophy
Apitegromab
October 2023
World Muscle Society 2023 Meeting
Effect of apitegromab on motor function at 36 months in patients with nonambulatory spinal muscular atrophy aged 2-12 years old
Fibrosis
SRK-373
September 2023
Discovery on Target 2023
Discovery and Antifibrotic Activity of an Anti-LTBP-TGFβ1 Inhibitory Antibody
Fibrosis
SRK-373
September 2023
Discovery on Target 2023
Discovery and Antifibrotic Activity of an Anti-LTBP-TGFβ1 Inhibitory Antibody
Spinal Muscular Atrophy
Apitegromab
June 2023
Cure SMA 2023 Annual SMA Conference
Effect of Apitegromab on Motor Function and PEDICAT and PROMIS at 36 Months in Patients with Type 2 and Nonambulatory Type 3 Spinal Muscular Atrophy: Combined Presentation of the Phase 2 TOPAZ Study
Spinal Muscular Atrophy
Apitegromab
March 2023
2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
